Up next

Autoplay

ER+/HER2+ Metastatic Breast Cancer

2 Views • 07/03/23
Share
Embed
administrator
administrator
Subscribers
0

Hope S. Rugo, MD, looks at the use of CDK4/6 inhibitors for patients with metastatic ER-positive, HER2-positive breast cancer and the trials evaluating their use in this setting.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay